![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis
Ruirui Zhao, Juhong Wu, Ling-Wu Tong, et al.
Journal of Colloid and Interface Science (2024) Vol. 660, pp. 257-276
Closed Access | Times Cited: 4
Ruirui Zhao, Juhong Wu, Ling-Wu Tong, et al.
Journal of Colloid and Interface Science (2024) Vol. 660, pp. 257-276
Closed Access | Times Cited: 4
Showing 4 citing articles:
The crosstalk between oncogenic signaling and ferroptosis in cancer
Qianghu Pang, Zhirou Tang, Lianxiang Luo
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104349-104349
Closed Access | Times Cited: 6
Qianghu Pang, Zhirou Tang, Lianxiang Luo
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104349-104349
Closed Access | Times Cited: 6
Self-assembled nanodrug based on ferroptosis inducer and sonosensitizer for enhanced sonodynamic-triggered multimodal synergistic therapy of prostate cancer
Yushuai Wu, Ruirui Zhao, Xiao Wu, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025) Vol. 208, pp. 114656-114656
Closed Access
Yushuai Wu, Ruirui Zhao, Xiao Wu, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025) Vol. 208, pp. 114656-114656
Closed Access
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 4
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 4
Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents
Pratibha Pandey, Deena Elsori, Rahul Kumar, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Pratibha Pandey, Deena Elsori, Rahul Kumar, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma
Xiu-Juan Yin, Jing Rong, Min Shao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Xiu-Juan Yin, Jing Rong, Min Shao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2